Consistent with the CD31 staining results, tumor cell proliferation marker Ki67 was also expressed abundantly in the control group, but treatments decreased similarly to CD31(Ki67 immunofluorescence staining in Fig. 6b and f). This evidence concerns the gene MKI67 and neoplasm.